Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Transcat Industry Stock Comparison

Sell
23

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
16.71
Seasonality Move:
-12.21%
Buy
62

TRNS
Transcat

Last Price:
121.40
Seasonality Move:
5.39%
Sell
23
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.07. The Score for BIS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Transcat (TRNS) is a Buy

Is Transcat a Buy, Sell or Hold?

  • The current Transcat [TRNS] share price is $121.59. The Score for TRNS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • TRNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.07
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

TRNS Stock Price Chart

What is Transcat's stock price today?

  • The Transcat share price today is $121.59
    The current trend is moderately bearish and TRNS is experiencing slight buying pressure.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 42.64 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.97 - 17.97) Sell
Bollinger Bands (100): (17.11 - 19.11) Sell

TRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.19 Buy
Relative Strength Index (14 RSI): 45.27 Sell
Chaikin Money Flow: 11200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.29 - 133.09) Sell
Bollinger Bands (100): (104.3 - 122.26) Buy

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.92 Buy
20-day SMA: 17.38 Sell
50-day SMA: 18.44 Sell
200-day SMA: 19.9 Sell
8-day EMA: 17.04 Buy
20-day EMA: 17.38 Sell
50-day EMA: 17.92 Sell
200-day EMA: 19.2 Sell

TRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.83 Sell
20-day SMA: 128.56 Sell
50-day SMA: 118.56 Buy
200-day SMA: 106.03 Buy
8-day EMA: 124.88 Sell
20-day EMA: 125.15 Sell
50-day EMA: 120.46 Buy
200-day EMA: 107.38 Buy

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Transcat Earnings Growth & TRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.27 per share, an increase this year of $0.68 per share, and an increase next year of $0.59 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Transcat Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):